These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1293127)

  • 1. Androgen regulation of programmed death of normal and malignant prostatic cells.
    Isaacs JT; Lundmo PI; Berges R; Martikainen P; Kyprianou N; English HF
    J Androl; 1992; 13(6):457-64. PubMed ID: 1293127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Programmed death of nonproliferating androgen-independent prostatic cancer cells.
    Martikainen P; Kyprianou N; Tucker RW; Isaacs JT
    Cancer Res; 1991 Sep; 51(17):4693-700. PubMed ID: 1873814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Programmed cell death as a new target for prostatic cancer therapy.
    Kyprianou N; Martikainen P; Davis L; English HF; Isaacs JT
    Cancer Surv; 1991; 11():265-77. PubMed ID: 1841755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of calcium, pH, and cell proliferation in the programmed (apoptotic) death of androgen-independent prostatic cancer cells induced by thapsigargin.
    Furuya Y; Lundmo P; Short AD; Gill DL; Isaacs JT
    Cancer Res; 1994 Dec; 54(23):6167-75. PubMed ID: 7954463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of programmed (apoptotic) cell death during the progression and therapy for prostate cancer.
    Denmeade SR; Lin XS; Isaacs JT
    Prostate; 1996 Apr; 28(4):251-65. PubMed ID: 8602401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Programmed cell death during regression of PC-82 human prostate cancer following androgen ablation.
    Kyprianou N; English HF; Isaacs JT
    Cancer Res; 1990 Jun; 50(12):3748-53. PubMed ID: 2340521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of androgen in the regulation of programmed cell death/apoptosis in normal and malignant prostatic tissue.
    Isaacs JT; Furuya Y; Berges R
    Semin Cancer Biol; 1994 Oct; 5(5):391-400. PubMed ID: 7849267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of intracellular calcium in the programmed cell death of prostatic cancer cells].
    Tombal B; Gailly P; Van Cangh PJ; Gillis JM
    Acta Urol Belg; 1995 Mar; 63(1):1-5. PubMed ID: 7537010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgens regulate vascular endothelial growth factor content in normal and malignant prostatic tissue.
    Joseph IB; Nelson JB; Denmeade SR; Isaacs JT
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2507-11. PubMed ID: 9815654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human prostatic cancer cells are sensitive to programmed (apoptotic) death induced by the antiangiogenic agent linomide.
    Vukanovic J; Isaacs JT
    Cancer Res; 1995 Aug; 55(16):3517-20. PubMed ID: 7543015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced expression of cyclin-dependent kinase inhibitor in apoptosis of androgen-independent prostatic cancer cell line induced by calcium ionophore.
    Furuya Y; Ohta S; Yasuda K; Ito H
    Anticancer Res; 1997; 17(4A):2391-4. PubMed ID: 9252652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-Jun N-terminal kinase is required for phorbol ester- and thapsigargin-induced apoptosis in the androgen responsive prostate cancer cell line LNCaP.
    Engedal N; Korkmaz CG; Saatcioglu F
    Oncogene; 2002 Feb; 21(7):1017-27. PubMed ID: 11850819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of an androgen receptor-null model for identifying the initiation site for androgen stimulation of proliferation and suppression of programmed (apoptotic) death of PC-82 human prostate cancer cells.
    Gao J; Isaacs JT
    Cancer Res; 1998 Aug; 58(15):3299-306. PubMed ID: 9699659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen blocks apoptosis of hormone-dependent prostate cancer cells.
    Kimura K; Markowski M; Bowen C; Gelmann EP
    Cancer Res; 2001 Jul; 61(14):5611-8. PubMed ID: 11454715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of bcl-2 and the progression of human and rodent prostatic cancers.
    Furuya Y; Krajewski S; Epstein JI; Reed JC; Isaacs JT
    Clin Cancer Res; 1996 Feb; 2(2):389-98. PubMed ID: 9816182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Programmed cell death in an estrogen-independent human breast cancer cell line, MDA-MB-468.
    Armstrong DK; Isaacs JT; Ottaviano YL; Davidson NE
    Cancer Res; 1992 Jun; 52(12):3418-24. PubMed ID: 1534511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential gene regulation during programmed death (apoptosis) versus proliferation of prostatic glandular cells induced by androgen manipulation.
    Furuya Y; Isaacs JT
    Endocrinology; 1993 Dec; 133(6):2660-6. PubMed ID: 8243289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The novel antimicrotubule agent cryptophycin 52 (LY355703) induces apoptosis via multiple pathways in human prostate cancer cells.
    Drew L; Fine RL; Do TN; Douglas GP; Petrylak DP
    Clin Cancer Res; 2002 Dec; 8(12):3922-32. PubMed ID: 12473608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of expression of Na+,K+-ATPase in androgen-dependent and androgen-independent prostate cancer.
    Blok LJ; Chang GT; Steenbeek-Slotboom M; van Weerden WM; Swarts HG; De Pont JJ; van Steenbrugge GJ; Brinkmann AO
    Br J Cancer; 1999 Sep; 81(1):28-36. PubMed ID: 10487609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgen deprivation induces selective outgrowth of aggressive hormone-refractory prostate cancer clones expressing distinct cellular and molecular properties not present in parental androgen-dependent cancer cells.
    Tso CL; McBride WH; Sun J; Patel B; Tsui KH; Paik SH; Gitlitz B; Caliliw R; van Ophoven A; Wu L; deKernion J; Belldegrun A
    Cancer J; 2000; 6(4):220-33. PubMed ID: 11038142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.